Market Insight: Pakistan govt seeks rich markets, but pharma stuck on price freeze
This article was originally published in Scrip
Executive Summary
The Pakistani government is keen to see its pharmaceutical industry reap the rewards of exporting to richer, regulated markets such as the EU and the US, but local companies seem to be more concerned with the price freeze on medicines introduced in 2001, delegates heard at a conference in London this week.